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Rabbit oral papillomavirus (ROPV) induces warts in mucosal tissues, and represents a useful model for understanding host–virus
interactions that are reflected in mucosal/HPV infections. ROPV induces benign papillomas that regress in 100% of infected rabbits. We
previously reported the complete genome sequence of ROPV. However, the oncogenic potential of this virus is unknown because of
immunologically mediated regression. The purpose of this study was to characterize the transforming proteins of E6, E7, and E8 genes of
ROPV. E6, E7, and E8 genes of ROPV were cloned into the expression vector PCR3. Two hybrid CRPV-ROPV E6 genes were also
constructed and tested together with the three wild-type ROPV genes. Each construct was transfected into NIH3T3 cells and stable
transfected cell lines were established. Transforming properties of ROPV E6, E7, and E8 were tested via anchorage-independent growth of
cells in agar plates and tumor growth in athymic mice. Cells with ROPV E6, E7, or E8 formed colonies in agar and tumors in athymic mice.
These observations suggest that ROPV E6, E7, and E8 are oncogenic.
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Rabbit oral papillomavirus (ROPV) causes benign
lesions on the tongue and the oral cavity of domestic rabbits
(Parsons and Kidd, 1936; Parsons and Kidd, 1942). Unlike
the cottontail rabbit papillomavirus (CRPV), which can
induce persistent papillomas and malignant tumors in cuta-
neous tissues, ROPV-induced lesions usually regress at
about 60 days after infection. Both rabbit viruses show
tissue and species restriction in infectivity. In early studies,
morphological features of ROPV-induced lesions were ex-
amined by electron microscopy (Rdzok et al., 1966; Richter
et al., 1964; Sundberg et al., 1985). We previously demon-
strated that infectious stocks of ROPV could be produced
from mouse xenografts of ROPV-infected rabbit tissue
(Christensen et al., 1996). In addition, a ROPV/rabbit
genital infection model was established in our laboratory
(Harvey et al., 1998). More recently, the genomic sequence
was published and serologic responses to ROPV major0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: ndc1@psu.edu (N.D. Christensen).capsid protein L1 were examined (Christensen et al.,
2000; O’Banion et al., 1988). Another study demonstrated
that immunization with peptides of the minor capsid protein,
L2, of ROPV provided protective immunity against virus
infection (Embers et al., 2002).
Finally, a recent study comparing the life cycle of
different papillomaviruses suggested that ROPV was an
appropriate virus system to study the life cycle of mucosal
HPV types and for the development of prophylactic vac-
cines (Peh et al., 2002).
The ROPV genome is about 8 kb in size and shows
similar organization of open reading frames (ORFs) with
that of CRPV (60% identical) and other PV genomes. There
are seven early ORFs (E1, E2, E4, E5, E6, E7, and E8) and
two late ORFs (L1 and L2). When amino acid sequences of
the ORFs of ROPV, CRPV, COPV, and BPV4 are com-
pared, CRPV shows highest similarity to ROPV in all the
viral proteins (Christensen et al., 2000; Han et al., 1998).
CRPV gene function has been well characterized and E6,
E7, E8, and E5 have been identified as oncogenes (Han et
al., 1998; Harry and Wettstein, 1996; Hu et al., 2002a;
Meyers et al., 1992). Using the CRPV DNA/rabbit infection
model, investigators identified that E6 and E7 genes are
essential for CRPV infection in vivo because CRPV E6 and
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However, E8 and E5 knockouts do not abrogate CRPV-
induced papillomas although E8 knockout genome demon-
strated reduced papilloma growth rate (Hu et al., 2002a). In
this study, we demonstrated that ROPV E6, E7, and E8 were
oncogenic with E8, showing weaker transforming activity to
E6 when tested for colony formation in soft agar and for
tumor growth in nude mice. To further characterize the
function of the ROPV E6 gene, we established two hybrid
CRPV-ROPV E6 genes and tested these hybrid proteins for
oncogenicity both in vitro and in vivo. Cells with both
hybrid E6 gene products formed cell colonies in soft agar
and one of them induced tumors in nude mice. Because
ROPV DNA/rabbit infection model has not been established
yet, we used CRPVDNA/rabbit infection model with the
hybrid ROPV E6 genes in the context of CRPV to test
oncogenicity and function of these hybrid genes in the
context of the whole viral genome.Results
ROPV E6, E7, E8, R-CE6*, and R-CE6** are transcribed
in vivo and translated in vitro
ROPV E6, E7, and E8 expression in transfectants was
determined by reverse-transcriptase polymerase chain reac-
tion (RT-PCR) to detect mRNA. Primer pairs specific for the
different genes were used. RNA extracted from the vector-
transfected cells was tested for amplification with all the
primer pairs as a control. No band was present from vector-
transfected cells while specific E6, E7, and E8 bands were
observed (data not shown).
To measure expression efficiencies, a coupled T7 tran-
scription/translation kit and Transcendk non-radioactive
translation detection system was used. As expected, positive
control (luciferase) showed a strong band at around 60 kDa.
Vector alone did not produce any product. ROPV E6, R-Fig. 1. (A) In vitro translation from various constructs. All viral genes were clon
microgram of each plasmid was used in the TNT Quick coupled transcription/
radioactive translation detection system. CRPV E6, CRPV E6G252E, R-CE6*, R-
product was larger than predicted and no E7 product was observed. (B) Express
negative control; lane 2 and 3 are the CRPV E7 products; lane 4 is the ROPV ECE6*, and R-CE6** expressed products at the expected size
(about 30 kDa). However, E8 produced a band that was
larger than its theoretically expected MW of 5–6 kDa and
no E7 product was detectable (Fig. 1A).
Because the reticulocyte lysate assay had been
reported to be problematic for the expression of HPV
E7 genes, we hypothesized that a similar problem might
exist in the expression of rabbit papillomavirus E7. We
thus applied the wheat germ extract systems to the
expression of these E7 genes. The corresponding bands
of the E7 products were detected using this expression
system (Fig. 1B).
Cell proliferation in cell lines transfected with ROPV genes
All viral gene-transfected cell lines showed increased
growth rates when compared to that of the vector-trans-
fected cells when grown in low concentrations of fetal
bovine serum (data not shown). When plated into soft
agar, these cell lines formed significantly more colonies
(diameter > 0.2 mm) than those of the cells containing
vector alone (Fig. 2). The ROPV E6-transfected line
showed more vigorous growth compared to cells contain-
ing R-CE6* and E8 (P < 0.05). However, no significant
differences were found in colony number between ROPV
E7-transfected cell lines and those containing E6, R-
CE6**, or E8.
Tumor formation in nude mice
Four athymic nu/nu mice per group were injected with
ROPV E6, E7, E8, and R-CE6** stably transfected cells
(5  106), respectively. Tumors appeared in mice injected
with ROPV E6 and E7-transfected cells 3 weeks later. The
nu/nu mice were sacrificed at week 5 after inoculation of
cells, and tumors were measured and harvested for histology
and immunoanalyses. The mean size of the tumors in mice
injected with cells containing ROPV E6 was significantlyed into the PCR3 expression vector and sequenced before expression. One
translation system (Promega, WI) and detected by the Transcendk non-
CE6**, and ROPV E6 were translated at the expected size. The ROPV E8
ion of ROPV E7 in wheat germ extract expression systems. Lane 1 is the
7 protein.
Fig. 2. Frequency of colonies in agar after P-Iodonitrotetrazolium violet (PI, Sigma) staining. Colonies larger than 0.2 mm in diameter were enumerated using
an auto count machine (Dynatech Laboratories, Inc. Imaging products). Significant differences were found between all the transfected cells when compared
with that of the control group. Data are representative of three individual experim
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CE6** cells. No significant difference was detected between
tumor sizes initiated from cell lines transfected with ROPV
E7, and E6 or E8. One small tumor was observed at a site
injected with vector only cells.
The tumors induced by the cells containing ROPV E6
was locally malignant as compared to tumors established
from cells containing ROPV E7, E8, and R-CE6** (Fig. 3).
ROPV E6 plus E7 genes were visible in these tumors by
DNA in situ hybridization (Fig. 4). The presence of each
gene in these tumors was identified by PCR amplification
(data not shown).Fig. 3. Tumor formation in nude mice following inoculation with different
transfected cells. Nude mice (5 – 6 weeks of age) were injected
subcutaneously with 5  106 ROPV E6, E7, E8, or vector-transfected
cells. Five weeks later, the mice were sacrificed and tumors were measured.
The geometric mean diameter (GMD) of individual tumors was calculated.
The bars represent the mean GMD F SE of each group of mice (N = 4).
Tumors from cells transfected with ROPV E6 induced larger tumors than
those of E8-transfected cells. No significant difference was noticed between
ROPV E7 versus tumors induced by cell transfected with E6 or E8.Growth of hybrid E6 CRPV genomes in rabbit skin
CRPV genomes containing the hybrid CRPV-ROPV E6-
E8 genes R-CE6* and R-CE6** (Fig. 5) were tested for
viability by inoculation onto scarified rabbit back skin.
Interestingly, neither construct produced papillomas. Wild-
type CRPV genomes produced papillomas under the same
experimental inoculation conditions (data not shown).
ents.Discussion
ROPV is a mucostropic papillomavirus that shares sim-
ilarity in life cycle with human mucosal papillomaviruses
(Peh et al., 2002). Analysis of ROPV gene function,
however, lags that of the more extensively studied rabbit
cutaneous CRPV. In this study, we described the character-
ization of three ROPVoncogenes and also included analysis
of two hybrid CRPV-ROPV E6 genes. These data provided
new information on the oncogenic potential of several
ROPV genes.
High-risk human papillomavirus E6 and E7 genes have
been widely studied because of their up-regulated expres-
sion in cervical carcinomas (Tommasino and Crawford,
1995; Von Knebel, 1992). These two genes are indispens-
able for cell transformation in vitro and for papilloma
formation in vivo (Harry and Wettstein, 1996; Schmitt et
al., 1994; Zhang et al., 1999). In contrast to wild-type
CRPV infection that induces persistent and malignant pap-
illomas in cutaneous tissues in domestic rabbits, ROPV-
induced lesions rarely became persistent. All of the lesions
regress via immunological mechanisms around 60 days after
infection (Christensen et al., 2000). This regression phe-
nomenon resembles a regressive CRPV strain and many
high- and low-risk genital human papillomavirus infections.
We had hypothesized that the apparent benign phenotype of
ROPV infections suggested that ROPV E6 and E7 might
Fig. 4. Histochemical analysis of the tumors harvested from the nude mice. (A) ROPV E6, (B) ROPV E7, (C) ROPV E8, and (D) R-CE6**-transfected cell
induced tumor tissue. Tumor cells in A showed a more invasive phenotype than those in B, C, and D; (E) in situ hybridization with ROPV E6 + E7 gene
fragment detected ROPV DNA in nuclear locations (dark blue dots, as identified by arrows).
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CRPV E6 and E7. However, immunologically mediated
regressions prevented such an analysis on intact host tissues.
Our results demonstrated that ROPV E6 and E7 showed
much higher transforming activities in vitro when compared
with their counterpart CRPV oncogenes. The ROPV E6-
transfected cell line induced tumors in nude mice with
invasive morphology. Despite high in vitro oncogenic
potential of ROPV E6, E7, and E8, ROPV causes benign
and regressive infections in rabbits. Several possibilities
may account for the benign nature of ROPV infection in
the context of the whole genome. The ROPV upstream
regulatory region (URR) was identified as a weaker pro-
moter when compared to that of CRPV (Peng, unpublished
observations). Alternatively, ROPV E6 may be highly
antigenic in vivo as found for the E6 protein of a regressive
strain of CRPV as described previously (Hu et al., 2002b;
Salmon et al., 1997). Thus, ROPV E6 may be a key
immunological target leading to ROPV-induced papilloma
regression.
ROPV E7 was not detected by in vitro Reticulocyte
Lysate Systems although we detected good levels of E7
transcription in transfected cell lines (data not shown). A
recent study showed that expression levels of E7 were
inhibited by a specific interaction between a peptide,SEQIKA, shared by Rabbit a1-Globin and Human Cyto-
keratin 7 and the viral transcript T (De Pasquale and
Kanduc, 1998; Kanduc, 2002). Similar regulatory events
may occur for both CRPVand ROPV E7 expression in vitro
because we also found CRPV E7 to be poorly expressed via
in vitro transcription (Han et al., 1999). However, E7
proteins were detectable by in vitro translation using the
Wheat Germ Extract Systems (Fig. 1B). In addition to
peptide inhibition, reduced expression of wild-type HPV-
16 E7 has been attributed to sub-optional codon usage (Cid-
Arregui and Juarez, 2003; Liu et al., 2002). We also
observed that the rabbit papillomavirus E7 proteins were
expressed at high levels in insect cells using recombinant
baculoviruses but at much lower or undetectable levels in
mammalian cells (Hu et al., unpublished data).
ROPV E8 is highly homologous in DNA sequence with
CRPV E8 but has only 40% identity in amino acid residues.
CRPV E8 has been identified as a weak oncogene but is
highly antigenic in vaccination studies. E8 also plays a role
in the appearance and outgrowth of CRPV-induced papillo-
mas (Hu et al., 2002a). In this study, we also found that
ROPV E8 has weaker transforming activity when compared
to ROPV E6.
Most interestingly, two hybrid CRPV-ROPV E6 genes
also showed high transforming activity in soft agar and one
Fig. 5. Generation of hybrid CRPV-ROPV E6 genes. Two enzyme sites (MscI and HpaI) at the borders of ROPVand CRPV E8 genes were introduced by site-
direct mutagenesis in ROPV E6 and CRPV E6, respectively. CRPV E8 or the carboxyl region of CRPV E6 (including E8) were replaced by ROPVand named
R-CE6* and R-CE6**. The highlighted residues are identical between CRPV and ROPV E6 and E8 genes.
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Using the same in vitro assays, we were not able to see
vigorous colony formation of the wild-type CRPV E6-
transfected cells although these cells showed proliferative
capacity in medium containing low fetal bovine serum. The
R-CE6** (CRPV E6 with the carboxyl terminal of ROPV
E6)-transfected cells formed significantly more colonies
than did cells transfected with CRPV E6 in the anchorage-
independent assay. In a previously published paper, some
CRPV E6 mutants were found to be more active in cell
transformation than was wild-type CRPV E6. These inves-
tigators hypothesized that mutations in E6 might lead toimproved binding of E6 to P53, E6AP, E6BP, etc. and thus
be more oncogenic (Harry and Wettstein, 1996; Meyers et
al., 1992). We did not determine whether ROPV E6 and the
hybrid CRPV-ROPV E6 proteins shared increased associa-
tions with P53, E6AP, or E6BP. Although R-CE6** gene-
transfected cells formed comparable numbers of colonies as
did ROPV E6 in soft agar, tumors in athymic mice were
smaller. A similar phenomenon was reported in previous
studies (Harry and Wettstein, 1996).
Our data imply that the carboxyl-terminal portion of
ROPV E6 (including E8) might be important for the
oncogenicity of this gene. Unfortunately, functional studies
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ROPV DNA infection in rabbits are not currently possible.
We have been unable to generate ROPV infections using
purified and/or plasmid-derived ROPV DNA. We did test
two CRPV constructs containing these two CRPV-ROPV
hybrid E6 genes, respectively, and found that they were not
able to induce cutaneous papillomas in rabbits.Materials and methods
Constructs
Primers for amplification of ROPV E6 (upstream
primer: 5V-AAT-TAG-ATC-TAT-GGA-GGA-GCG-CCA-
CGC-ACC-TTG-G-3V; downstream primer: 5V-CGG-
GGG-ATC-CTG-AGC-AAG-AAG-CTT-AAA-CGT-TAA-
T-3V), E7 (upstream primer: 5V-ATG-CAA-GCT-TAT-GAT-
AGG-CCC-CAA-GCC-TAC-CCT-T-3V; downstream prim-
er: 5V-GCC-AGA-TAT-CTT-CAG-CCA-TTT-TTC-AGA-
CGT-TTG-C-3V), and E8 (upstream primer: 5V-GGA-
TCC-ACG-GGT-GGC-CTC-ATG-G-3V; downstream prim-
er: 5V-GGT-ACC-AGA-CGT-AGT-TAG-CAC-TC-3V) were
synthesized in the core facility at the Hershey Medical
Center and designed from the published ROPV sequence
(Christensen et al., 2000). For construction of the two hybrid
CRPV-ROPV E6 genes, two restriction enzyme sites were
introduced by site-directed mutagenesis at the borders of
both CRPV E8 and ROPV E8 in CRPV and ROPV E6
subclones. Hybrid CRPV-ROPV E8 (R-CE6*) represented
the E8 of CRPV replaced by ROPV E8, and hybrid CRPV-
ROPV E6 (R-CE6**) represented the carboxyl-terminal
region of CRPV E6 (including CRPV E8) replaced by the
equivalent part of ROPV (Fig. 5). The rationale for con-
struction of these two hybrid E6 genes was to test the role of
ROPV E8 (e.g. construct R-CE6*) in vivo in the context of
potential infectability within CRPV genome. The second
construct replaced CRPV E6 (with ROPV E8) and generated
a CRPV-ROPV E6 hybrid gene that replaced the highly
antigenic carboxyl-terminal portion of CRPV E6with ROPV
E6 to test altered host immune responses (Hu et al., 2002b).
All genes were cloned into an expression vector (PCR3),
which contained a neomycin (G-418) resistance gene under
the control of the CMV promoter (Invitrogen) and constructs
were verified by automated sequencing.
Cell culture and transfections
NIH3T3 cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum and penicillin (100 units/ml) and streptomycin
(100 Ag/ml). Detachment and dispersion of cells was
achieved by a brief exposure to 0.25% trypsin, 0.02%
EDTA in PBS.
All transfections were performed by calcium phosphate
precipitation (Han et al., 1998). Cells used for DNAtransfection were plated at 70% confluence in T-25
flasks. Ten micrograms of circular plasmid DNA was
used in transfections. G-418 (Geneticin, Gibco BRL)-
resistant selection began 24 h after DMSO shock by
the addition of 1 mg/ml G-418. G418-resistant colonies
were pooled after a 2-week period of selection and
maintained with medium containing 1 mg/ml G418. All
cell cultures were maintained at 37 jC in a 5% CO2
humidified atmosphere.
Detection of gene transcription by RT-PCR
The transcripts of ROPV E6, E7, E8, R-CE6*, R-CE6**,
and vector-transfected NIH3T3 cells were detected by
standard RT-PCR analysis. In brief, total RNA from each
stable transfected cell line (1  106 cells) was extracted with
Trizol reagent (Gibco BRL) and amplified using an RT-PCR
reaction kit (Roche) with corresponding primers.
In vitro translation
One microgram of each expression construct was trans-
lated with non-radioactive TNT Quick T7 coupled Transcrip-
tion/Translation kit (Promega) according to the protocol
provided by the manufacturer. Onemicroliter of final reaction
product was mixed with 10 Al protein loading buffer and
denatured at 100 jC for 5 min. The samples were separated
using sodium dodecyl sulfate-polyacrylamide gel electropho-
resis (12%) and transferred to polyvinylidene difluoride
(PVDF) membranes. After blocking and incubation with
avidin-AP, the proteins were detected with the Transcendk
non-radioactive translation detection system (Promega).
CRPV E7 and ROPV E7 products were expressed in
TNTR Coupled Wheat Germ Extract Systems (Promega)
according to the protocol provided by the manufacturer.
[35S]methionine was incorporated into the expressed pro-
teins. Five microliters of final reaction product was mixed
with 20 Al protein loading buffer and denatured at 100 jC
for 5 min. The samples were separated using SDS-poly-
acrylamide gel electrophoresis (12%). The gel was placed
on a sheet of WhatmanR 3MM filter paper, and dried at
80 jC for 30–90 min under a vacuum using a conventional
gel dryer. The dried gel was exposed on X-ray film for 1–6 h
at70 jC.
Cell growth and anchorage-independent assay
5 103 cells from vector, ROPV E6, E7, E8, R-CE6*, and
R-CE6**-transfected cells were plated into 96-well plates
with culture medium containing 2% fetal bovine serum. The
cells were stained with MTT (7.5 mg/ml medium) for 3 h at
37 jC then lysed with lysis buffer (10% Triton X-100, 0.01 N
HCl in isopropyl alcohol). The absorbance of the solubilized
purple dye released by live cells was determined at 570 nm
using an automated microplate reader (Opsys MRk, Ther-
molabsystems). The mean OD value of duplicate cultures for
J. Hu et al. / Virology 325 (2004) 48–5554each cell was calculated. Growth curves were plotted as mean
OD values against time after the cells were seeded. For
detection of anchorage-independent growth, 2  105 pooled
and expanded G-418-resistant cells from selected cell lines
were plated in 60-mm petri dishes with medium containing
0.3% agar Noble (DiFco Laboratories). The dishes contained
a bottom layer of 0.5% Nobel agar in medium containing G-
418. Cells were fed twice weekly with 1 ml of 0.3% Noble
agar medium. Five weeks after seeding, colonies were stained
with P-Iodonitrotetrazolium Violet (2-[4-Iodophenyl]-3-[-4-
nitrophenyl]-5-phenyltetrazolium chloride, Sigma) overnight
at 37 jC in the dark. Colonies greater than 0.2mm in diameter
were enumerated using an auto count machine (Dynatech
Laboratories, Inc.).
Tumorigenesis assay
5  106 pooled and expanded G-418-resistant cells from
ROPV E6, E7, E8, and R-CE6**-transfected cell lines,
respectively, were injected subcutaneously into individual
nude mice. Tumor formation was checked weekly after the
cell inoculation. Five weeks later, the nude mice were
sacrificed and the tumors were measured and tumor tissues
fixed in formalin for histological examination.
Growth of CRPV genomes with hybrid E6 genes in vivo
Hybrid CRPV-ROPV E6 genes (Fig. 5) were replaced
into the entire CRPV genome using procedures previously
described (Hu et al., 2002b). The modified genomes were
tested for infectivity on NZW rabbit cutaneous sites follow-
ing inoculation of 10 Ag DNA per site onto scarified
hyperplastic skin as previously described (Hu et al., 2002b).
Statistical analyses
The mean size of the tumors was determined by geo-
metric mean diameter (GMD). Differences in mean tumor
size between the groups were determined by Student’s T test
at P < 0.05 level of significance.Acknowledgments
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